Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set?
暂无分享,去创建一个
P. Halban | S. Kahn | C. Rhodes | Lernmark A
[1] J. Itskovitz‐Eldor,et al. Insulin production by human embryonic stem cells. , 2001, Diabetes.
[2] B. Wicksteed,et al. Cooperativity between the Preproinsulin mRNA Untranslated Regions Is Necessary for Glucose-stimulated Translation* , 2001, The Journal of Biological Chemistry.
[3] B. Topp,et al. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. , 2001, Diabetes.
[4] R. McKay,et al. Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets , 2001, Science.
[5] J F Elliott,et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. , 2001, Diabetes.
[6] F. Levine,et al. Gene therapy for diabetes. , 2001, Frontiers in bioscience : a journal and virtual library.
[7] D. Drucker,et al. Minireview: the glucagon-like peptides. , 2001, Endocrinology.
[8] J. Bryan,et al. Of mice and men: K(ATP) channels and insulin secretion. , 2001, Recent progress in hormone research.
[9] D. Kendall,et al. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. , 2001, Diabetes.
[10] G. Korbutt,et al. Glucose-dependent insulin release from genetically engineered K cells. , 2000, Science.
[11] Hyun Chul Lee,et al. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue , 2000, Nature.
[12] J. Henquin,et al. Triggering and amplifying pathways of regulation of insulin secretion by glucose. , 2000, Diabetes.
[13] F. Bertuzzi,et al. Development and Characterization of Pituitary GH3 Cell Clones Stably Transfected with a Human Proinsulin cDNA , 2000, Cell transplantation.
[14] M. Meseck,et al. Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells , 2000, Gene Therapy.
[15] M. Prentki,et al. Metabolic control of -cell function , 2000 .
[16] P. Halban,et al. Trafficking/sorting and granule biogenesis in the beta-cell. , 2000, Seminars in cell & developmental biology.
[17] M. German,et al. Regulation of insulin gene transcription. , 2000, Seminars in cell & developmental biology.
[18] J. Hutton,et al. Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic beta-cell. , 2000, Seminars in cell & developmental biology.
[19] E. Ryan,et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.
[20] S. Bonner-Weir,et al. In vitro cultivation of human islets from expanded ductal tissue. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Prentki,et al. Acute Stimulation with Long Chain Acyl-CoA Enhances Exocytosis in Insulin-secreting Cells (HIT T-15 and NMRI β-Cells)* , 2000, The Journal of Biological Chemistry.
[22] M. Rewers,et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] L. Phillips,et al. Glucose regulated production of human insulin in rat hepatocytes , 2000, Gene Therapy.
[24] M. Prentki,et al. Metabolic control of beta-cell function. , 2000, Seminars in cell & developmental biology.
[25] B. AhrØn,et al. Autonomic regulation of islet hormone secretion ± Implications for health and disease , 2000 .
[26] C. Wollheim,et al. Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells. , 1999, The Journal of clinical investigation.
[27] M. Atkinson,et al. The NOD mouse model of type 1 diabetes: As good as it gets? , 1999, Nature Medicine.
[28] M. Nauck. Is glucagon-like peptide 1 an incretin hormone? , 1999, Diabetologia.
[29] D. Bruttomesso,et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. , 1999, Diabetes.
[30] K. Docherty,et al. Prospects for insulin delivery by ex-vivo somatic cell gene therapy , 1999, Journal of Molecular Medicine.
[31] S. Efrat. Prospects for gene therapy of insulin-dependent diabetes mellitus , 1998, Diabetologia.
[32] P A Cleary,et al. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. , 1998, JAMA.
[33] K. Salmela,et al. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft , 1998, Diabetologia.
[34] N. Seidah,et al. Proprotein Convertases , 2011, Methods in Molecular Biology.
[35] P. Halban,et al. Release of Incompletely Processed Proinsulin Is the Cause of the Disproportionate Proinsulinemia of NIDDM , 1997, Diabetes.
[36] A. Simpson,et al. Gene therapy of diabetes: glucose-stimulated insulin secretion in a human hepatoma cell line (HEP G2ins/g) , 1997, Gene Therapy.
[37] R. Gruessner,et al. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. , 1997, Clinical transplantation.
[38] M. Prentki,et al. Metabolic Fate of Glucose in Purified Islet Cells , 1997, The Journal of Biological Chemistry.
[39] C. Newgard,et al. Engineered cell lines for insulin replacement in diabetes: current status and future prospects , 1997, Diabetologia.
[40] P. Muzzin,et al. Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. , 1997, Molecular endocrinology.
[41] M. Hammami. Diabetes Mellitus: A Fundamental and Clinical Text , 1997 .
[42] R N Bergman,et al. Role of Glucose Effectiveness in the Determination of Glucose Tolerance , 1996, Diabetes Care.
[43] K. Matsumoto,et al. High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. , 1996, The Journal of clinical endocrinology and metabolism.
[44] D. Sutherland,et al. Use of FK 506 in pancreas transplantation. , 1996, Transplant international : official journal of the European Society for Organ Transplantation.
[45] B. Göke,et al. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. , 1995, Endocrine reviews.
[46] C. Newgard,et al. Metabolic coupling factors in pancreatic beta-cell signal transduction. , 1995, Annual review of biochemistry.
[47] R N Bergman,et al. The Contribution of Insulin-Dependent and Insulin-Independent Glucose Uptake to Intravenous Glucose Tolerance in Healthy Human Subjects , 1994, Diabetes.
[48] F. Bosch,et al. Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] P. Halban,et al. Sorting and processing of secretory proteins. , 1994, The Biochemical journal.
[50] M. Sliwkowski,et al. Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. , 1994, The Journal of biological chemistry.
[51] R. Bergman,et al. Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.
[52] B. Sobel,et al. Stimulation by Proinsulin of Expression of Plasminogen Activator Inhibitor Type-I in Endothelial Cells , 1992, Diabetes.
[53] M. Cerqueira,et al. Exercise training delineates the importance of B-cell dysfunction to the glucose intolerance of human aging. , 1992, The Journal of clinical endocrinology and metabolism.
[54] M. Cerqueira,et al. Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. , 1990, The American journal of physiology.
[55] G. Ward,et al. Effects of Prolonged Pulsatile Hyperinsulinemia in Humans: Enhancement of Insulin Sensitivity , 1990, Diabetes.
[56] D. Sutherland,et al. Recurrence of Disease in Pancreas Transplants , 1989, Diabetes.
[57] A. Baron,et al. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. , 1988, The American journal of physiology.
[58] E. Kraegen,et al. Physiological Importance of Deficiency in Early Prandial Insulin Secretion in Non-Insulin-Dependent Diabetes , 1988, Diabetes.
[59] P. Russell,et al. Regulation of insulin-gene expression. Implications for gene therapy. , 1987 .
[60] R. Henry,et al. The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitus. , 1987, The New England journal of medicine.
[61] R. Boston,et al. Metabolic Consequences of Prolonged Hyperinsulinemia in Humans: Evidence for Induction of Insulin Insensitivity , 1986, Diabetes.
[62] R. Kelly. Pathways of protein secretion in eukaryotes. , 1985, Science.
[63] M. Löhr,et al. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. , 1985, Survey and synthesis of pathology research.
[64] J. Halter,et al. Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men. , 1984, The American journal of physiology.
[65] J. Halter,et al. Pathophysiology of Insulin Secretion in Non-insulin-dependent Diabetes Mellitus , 1984, Diabetes Care.
[66] R. Kelly,et al. Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation , 1983, Cell.
[67] H. Hendrickson. Prevention of what? , 1983, Journal of the American Optometric Association.
[68] Philippe Soriano,et al. In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[69] S. Kalhan,et al. Inhibitory effect of prednisone on insulin secretion in man: model for duplication of blood glucose concentration. , 1975, The Journal of clinical endocrinology and metabolism.